Jacobs BC - Search Results

1

Neurological disease in adults with Zika and chikungunya virus infection in Northeast Brazil: a prospective observational study.

Brito Ferreira ML, Militão de Albuquerque MFP, de Brito CAA, de Oliveira França RF, Porto Moreira ÁJ, de Morais Machado MÍ, da Paz Melo R, Medialdea-Carrera R, Dornelas Mesquita S, Lopes Santos M, Mehta R, Ramos E Silva R, Leonhard SE, Ellul M, Rosala-Hallas A, Burnside G, Turtle L, Griffiths MJ, Jacobs BC, Bhojak M, Willison HJ, Pena LJ, Pardo CA, Ximenes RAA, Martelli CMT, Brown DWG, Cordeiro MT, Lant S, Solomon T. Brito Ferreira ML, et al. Among authors: jacobs bc. Lancet Neurol. 2020 Oct;19(10):826-839. doi: 10.1016/S1474-4422(20)30232-5. Epub 2020 Sep 16. Lancet Neurol. 2020. PMID: 32949543 Free PMC article.

2

Detection and prevalence of alpha-latrotoxin-like effects of serum from patients with Guillain-Barré syndrome.

Jacobs BC, Bullens RW, O'Hanlon GM, Ang CW, Willison HJ, Plomp JJ. Jacobs BC, et al. Muscle Nerve. 2002 Apr;25(4):549-58. doi: 10.1002/mus.10060. Muscle Nerve. 2002. PMID: 11932973

3

Immunoglobulins inhibit pathophysiological effects of anti-GQ1b-positive sera at motor nerve terminals through inhibition of antibody binding.

Jacobs BC, O'Hanlon GM, Bullens RW, Veitch J, Plomp JJ, Willison HJ. Jacobs BC, et al. Brain. 2003 Oct;126(Pt 10):2220-34. doi: 10.1093/brain/awg235. Epub 2003 Jul 22. Brain. 2003. PMID: 12876146

4

A clinical prognostic scoring system for Guillain-Barré syndrome.

van Koningsveld R, Steyerberg EW, Hughes RA, Swan AV, van Doorn PA, Jacobs BC. van Koningsveld R, et al. Among authors: jacobs bc. Lancet Neurol. 2007 Jul;6(7):589-94. doi: 10.1016/S1474-4422(07)70130-8. Lancet Neurol. 2007. PMID: 17537676

5

Subclass IgG to motor gangliosides related to infection and clinical course in Guillain-Barré syndrome.

Jacobs BC, Koga M, van Rijs W, Geleijns K, van Doorn PA, Willison HJ, Yuki N. Jacobs BC, et al. J Neuroimmunol. 2008 Feb;194(1-2):181-90. doi: 10.1016/j.jneuroim.2007.11.017. Epub 2008 Feb 21. J Neuroimmunol. 2008. PMID: 18178257

6

Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model.

Halstead SK, Zitman FM, Humphreys PD, Greenshields K, Verschuuren JJ, Jacobs BC, Rother RP, Plomp JJ, Willison HJ. Halstead SK, et al. Among authors: jacobs bc. Brain. 2008 May;131(Pt 5):1197-208. doi: 10.1093/brain/awm316. Epub 2008 Jan 8. Brain. 2008. PMID: 18184663

7

Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome.

van Doorn PA, Ruts L, Jacobs BC. van Doorn PA, et al. Among authors: jacobs bc. Lancet Neurol. 2008 Oct;7(10):939-50. doi: 10.1016/S1474-4422(08)70215-1. Lancet Neurol. 2008. PMID: 18848313 Review.

8

Peripheral neuropathies: Biomarkers for axonal damage in immune-mediated neuropathy.

Jacobs BC, Willison HJ. Jacobs BC, et al. Nat Rev Neurol. 2009 Nov;5(11):584-5. doi: 10.1038/nrneurol.2009.161. Nat Rev Neurol. 2009. PMID: 19888315 No abstract available.

9

Sialylation of Campylobacter jejuni lipo-oligosaccharides: impact on phagocytosis and cytokine production in mice.

Huizinga R, Easton AS, Donachie AM, Guthrie J, van Rijs W, Heikema A, Boon L, Samsom JN, Jacobs BC, Willison HJ, Goodyear CS. Huizinga R, et al. Among authors: jacobs bc. PLoS One. 2012;7(3):e34416. doi: 10.1371/journal.pone.0034416. Epub 2012 Mar 28. PLoS One. 2012. PMID: 22470569 Free PMC article.

10

Mortality in Guillain-Barre syndrome.

van den Berg B, Bunschoten C, van Doorn PA, Jacobs BC. van den Berg B, et al. Among authors: jacobs bc. Neurology. 2013 Apr 30;80(18):1650-4. doi: 10.1212/WNL.0b013e3182904fcc. Epub 2013 Apr 10. Neurology. 2013. PMID: 23576619

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

280 results

Search Page